Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials

被引：0
|
作者：
Irimia Sieira, P. [1 ]
Torphy, B. [2 ]
Ortega, M. [3 ]
Barash, S. [3 ]
Krasenbaum, L. J. [3 ]
Akcicek, H. [4 ]
Smith, M. [2 ]
Ning, X. [3 ]
Campos, V. Ramirez [3 ]
机构：
[1] Clin Univ Navarra, Neurol Dept, Pamplona, Spain
[2] Chicago Headache Ctr & Res Inst, Chicago, IL USA
[3] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[4] Teva Netherlands BV, Amsterdam, Netherlands
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P035
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and Efficacy of Fremanezumab for Migraine Prevention over 6 Months: Pooled Analysis of the Phase 3 FOCUS and HALO Studies
    Charleston, Larry
    Campos, Verena Ramirez
    Ning, Xiaoping
    Krasenbaum, Lynda J.
    Kessler, Yoel
    Ojwang, Beryl
    Nahas, Stephanie
    ANNALS OF NEUROLOGY, 2022, 92 : S42 - S42
  • [2] Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine
    Yang, Chun-Pai
    Lee, Chia-Fang
    Dell'Agnello, Grazia
    Hundemer, Hans-Peter
    Lipsius, Sarah
    Wang, Shuu-Jiun
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1653 - 1666
  • [3] Lasmiditan in Patients with Common Migraine Comorbidities: A Post hoc, Safety, and Efficacy Analysis of Two Phase 3 Randomized Clinical Trials
    Clemow, D. B.
    Baygani, S. K.
    Hauck, P. M.
    Hultman, C. B.
    Wilhelm, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1094 - 1094
  • [4] Lasmiditan in Patients with Common Migraine Comorbidities: A Post hoc, Safety, and Efficacy Analysis of Two Phase 3 Randomized Clinical Trials
    Clemow, David
    Baygani, Simin
    Hauck, Paula
    Hultman, Cory
    NEUROLOGY, 2020, 94 (15)
  • [5] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [6] Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States
    Varnado, Oralee J.
    Ye, Wenyu
    Mi, Xiaojuan
    Burge, Russel
    Hall, Jerry
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 149 - 157
  • [7] Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
    Conaghan, Philip G.
    Pavelka, Karel
    Hsieh, Song-Chou
    Bonnington, Terri-Leigh
    Kent, Toby C.
    Marchbank, Katie
    Edwards, Christopher J.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 7 (01)
  • [8] Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
    Lipton, Richard B.
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Halker Singh, Rashmi B.
    Ailani, Jessica
    HEADACHE, 2020, 60 (10): : 2444 - 2453
  • [9] Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials
    Edwards, Christopher J.
    Roshak, Katherine
    Bukowski, Jack F.
    Pedersen, Ronald
    Thakur, Mazhar
    Borlenghi, Cecilia
    Curiale, Cinzia
    Jones, Heather
    Marshall, Lisa
    DRUGS & AGING, 2019, 36 (09) : 853 - 862
  • [10] Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials
    Christopher J. Edwards
    Katherine Roshak
    Jack F. Bukowski
    Ronald Pedersen
    Mazhar Thakur
    Cecilia Borlenghi
    Cinzia Curiale
    Heather Jones
    Lisa Marshall
    Drugs & Aging, 2019, 36 : 853 - 862
12345